etoricoxib teva 120 mg apvalkotās tabletes
teva b.v., netherlands - etorikoksibs - apvalkotā tablete - 120 mg
etoricoxib zentiva 90 mg apvalkotās tabletes
zentiva, k.s., czech republic - etorikoksibs - apvalkotā tablete - 90 mg
etoricoxib zentiva 60 mg apvalkotās tabletes
zentiva, k.s., czech republic - etorikoksibs - apvalkotā tablete - 60 mg
etoricoxib zentiva 120 mg apvalkotās tabletes
zentiva, k.s., czech republic - etorikoksibs - apvalkotā tablete - 120 mg
etidylan 90 mg apvalkotās tabletes
g.l. pharma gmbh, austria - etorikoksibs - apvalkotā tablete - 90 mg
etidylan 120 mg apvalkotās tabletes
g.l. pharma gmbh, austria - etorikoksibs - apvalkotā tablete - 120 mg
etidylan 60 mg apvalkotās tabletes
g.l. pharma gmbh, austria - etorikoksibs - apvalkotā tablete - 60 mg
sarclisa
sanofi winthrop industrie - isatuximab - multiple mieloma - antineoplastiski līdzekļi - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
prostarinol 5 mg apvalkotās tabletes
olainfarm, as, latvia - finasterīds - apvalkotā tablete - 5 mg
thromboreductin 0,5 mg cietās kapsulas
aop orphan pharmaceuticals gmbh, austria - anagrelīda hidrohlorīds - kapsula, cietā - 0,5 mg